Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial Comparing Insulin Degludec and Glargine U100 for the Inpatient and Post-Hospital Discharge Management of Medicine and Surgery Patients With Type 2 Diabetes

NCT03336528 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT03336528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03336528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial Comparing Insulin Degludec and Glargine U100 for the Inpatient and Post-Hospital Discharge Management of Medicine and Surgery Patients With Type 2 Diabetes
Lead sponsor
Emory University
Phase
Phase 4
Overall status
Completed
Start date
January 2, 2018
Completion date
March 1, 2021
Enrollment
180 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes